Cargando…
Persistence of Immune Response in Health Care Workers After Two Doses BNT162b2 in a Longitudinal Observational Study
BACKGROUND: The mRNA-based vaccine BNT162b2 of BioNTech/Pfizer has shown high efficacy against SARS-CoV-2 infection and a severe course of the COVID-19 disease. However, little is known about the long-term durability of the induced immune response resulting from the vaccination. METHODS: In a longit...
Autores principales: | Herzberg, Jonas, Fischer, Bastian, Lindenkamp, Christopher, Becher, Heiko, Becker, Ann-Kristin, Honarpisheh, Human, Guraya, Salman Yousuf, Strate, Tim, Knabbe, Cornelius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931311/ https://www.ncbi.nlm.nih.gov/pubmed/35309303 http://dx.doi.org/10.3389/fimmu.2022.839922 |
Ejemplares similares
-
Short-Term Drop in Antibody Titer after the Third Dose of SARS-CoV-2 BNT162b2 Vaccine in Adults
por: Herzberg, Jonas, et al.
Publicado: (2022) -
Cellular and Humoral Immune Response to a Third Dose of BNT162b2 COVID-19 Vaccine – A Prospective Observational Study
por: Herzberg, Jonas, et al.
Publicado: (2022) -
SARS-CoV-2-antibody response in health care workers after vaccination or natural infection in a longitudinal observational study
por: Herzberg, Jonas, et al.
Publicado: (2022) -
Prospective Sero-epidemiological Evaluation of SARS-CoV-2 among Health Care Workers in a German Secondary Care Hospital
por: Herzberg, Jonas, et al.
Publicado: (2021) -
Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees
por: Herzberg, Jonas, et al.
Publicado: (2021)